| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/06/2005 | WO2005040218A1 METHOD FOR PREPARING COMPOSITE IgY SPECIFIC AGAINST PERIODONTAL DISEASE AND COMPOSITE PREPARATION THEREOF |
| 05/06/2005 | WO2005040217A2 Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions |
| 05/06/2005 | WO2005040216A2 Use of metallic cations to improve functional activity of antibodies |
| 05/06/2005 | WO2005040206A1 Glurp-msp3 fusion protein, immunogenic compositions and malarial vaccines containing it |
| 05/06/2005 | WO2005040194A2 Methods and compositions for pdgf-c activation and inhibition |
| 05/06/2005 | WO2005039613A1 Lim2 inhibitor of lm02 |
| 05/06/2005 | WO2005039393A2 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 05/06/2005 | WO2005026314A3 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| 05/06/2005 | WO2005003775A3 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 05/06/2005 | WO2005003169A3 Modified antibody fab fragments |
| 05/06/2005 | WO2005003168A3 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
| 05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 05/06/2005 | WO2005000349A3 Passive immune therapy against malignant melanoma |
| 05/06/2005 | WO2005000223A3 Method of treating retinopathies and disorders associated with blood vessel loss |
| 05/06/2005 | WO2004110345A8 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 05/06/2005 | WO2004081027B1 Neoplasm specific antibodies and uses thereof |
| 05/06/2005 | WO2004080419A3 Humanized antibodies that recognize beta amyloid peptide |
| 05/06/2005 | WO2004080418A3 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 05/06/2005 | WO2004078776A3 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 05/06/2005 | WO2004071529A3 Uses of anti-insulin-like growth factor i receptor antibodies |
| 05/06/2005 | WO2004052933B1 Peptide oligomers for use as hiv vaccines |
| 05/06/2005 | WO2004044220A3 Flaviviris fusion inhibitors |
| 05/06/2005 | WO2004035537A8 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 05/06/2005 | WO2004000217A3 Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| 05/06/2005 | WO2003072607A8 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins |
| 05/06/2005 | WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/06/2005 | CA2544099A1 Peptides with anti-obesity activity and other related uses |
| 05/06/2005 | CA2543789A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/06/2005 | CA2543779A1 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 05/06/2005 | CA2542928A1 Use of metallic cations to improve functional activity of antibodies |
| 05/06/2005 | CA2542924A1 Msp-3-like family of genes |
| 05/06/2005 | CA2542881A1 Antibody with an optimized fucose content/galactose content ratio |
| 05/06/2005 | CA2542686A1 Colorectal cancer antigen |
| 05/06/2005 | CA2542239A1 Multispecific deimmunized cd3-binders |
| 05/06/2005 | CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 05/06/2005 | CA2541868A1 Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions |
| 05/05/2005 | US20050097634 Methods of increasing polypeptide accumulation in plants |
| 05/05/2005 | US20050097627 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/05/2005 | US20050097625 Generating trangenic mammal in which somatic and germ cell comprisie heavy chain variable region of immunoglobulins; bioreactors for production of preferential immunoglobulins in milk |
| 05/05/2005 | US20050096484 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 05/05/2005 | US20050096460 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 05/05/2005 | US20050096459 Oligomeric receptor ligand pair member complexes |
| 05/05/2005 | US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics |
| 05/05/2005 | US20050096339 for alleviating immune-cell mediated tissue destruction associated with the inflammatory response |
| 05/05/2005 | US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050096260 Metal complex-protein composite and oxidation catalyst |
| 05/05/2005 | US20050095726 Novel high protein tortillas |
| 05/05/2005 | US20050095685 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
| 05/05/2005 | US20050095676 Novel glycoproteins and methods of use thereof |
| 05/05/2005 | US20050095671 Nucleotide sequences coding splice variant of ubiquination regulatory protein for use in prevention and treatment of neurodegenerative disorders |
| 05/05/2005 | US20050095650 screening for an agent that modulates capsaicin receptor function |
| 05/05/2005 | US20050095631 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 05/05/2005 | US20050095612 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/05/2005 | US20050095584 Method for determining early HCV seroconversion |
| 05/05/2005 | US20050095581 Viral polypeptide for use as tool in generating immunoreactive particle for diagnosis, prevention and treatment of viral infection |
| 05/05/2005 | US20050095282 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 05/05/2005 | US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells |
| 05/05/2005 | US20050095254 DNA immunization against Chlamydia infection |
| 05/05/2005 | US20050095250 treating breast concer by administering a monoclonal antibody with an oligo- beta -(1,3)-glucan and a carrier |
| 05/05/2005 | US20050095249 Protein markers for lung cancer and use thereof |
| 05/05/2005 | US20050095246 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 05/05/2005 | US20050095244 Monoclonal antibodies or antigen binding portions; anticancer agents |
| 05/05/2005 | US20050095243 Contacting the mixed population of cells with a BLyS(B lymphocte stimulator) antagonist and a CD20 antigen binding antibody; immunoadhesin; B cell neoplasm or a B-cell regulated autoimmune disorder |
| 05/05/2005 | US20050095242 Diagnostics and remedies for interstitial pneumonia |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/05/2005 | US20050095240 NaCT as a target for lifespan expansion and weight reduction |
| 05/05/2005 | US20050095239 Methods and compositions for treating Alzheimer's disease |
| 05/05/2005 | US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin |
| 05/05/2005 | US20050095236 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 05/05/2005 | CA2446460A1 Identification of a novel bovine immunodeficiency-like virus tat protein with enhanced transactivation activity |
| 05/04/2005 | EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins |
| 05/04/2005 | EP1527190A2 Hip1 cancer markers |
| 05/04/2005 | EP1527189A2 Mutant proteinase inhibitors and uses thereof |
| 05/04/2005 | EP1527179A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 05/04/2005 | EP1527178A2 Novel class ii cytokine receptors and uses thereof |
| 05/04/2005 | EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 05/04/2005 | EP1527101A2 Specific antibodies for diagnosing heart failure |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527099A2 Mutants of ige proteins and uses thereof |
| 05/04/2005 | EP1527098A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 05/04/2005 | EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 05/04/2005 | EP1527080A2 Campylobacter glycans and glycopeptides |
| 05/04/2005 | EP1526868A2 Antibodies |
| 05/04/2005 | EP1506312A4 Metalloprotease peptide substrates and methods |
| 05/04/2005 | EP1362062B1 Concatameric immunoadhesion |
| 05/04/2005 | EP1315520B1 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 05/04/2005 | EP1313503A4 Human tumor necrosis factor receptors tr21 and tr22 |
| 05/04/2005 | EP1065214B1 Novel physiologically active peptides and utilization thereof |
| 05/04/2005 | EP1037990B1 Human sel-10 polypeptides and polynucleotides that encode them |
| 05/04/2005 | EP0835266B1 Modified/chimeric superantigens and their use |
| 05/04/2005 | EP0831907A4 Method for treating molluscum contagiosum resulting from hiv infection |
| 05/04/2005 | EP0804734B1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| 05/04/2005 | EP0668916B1 Haemophilus outer membrane protein |
| 05/04/2005 | CN1612942A Viral capsid assembly intermediates |
| 05/04/2005 | CN1612934A Human monoclonal antibodies to dendritic cells |
| 05/04/2005 | CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/04/2005 | CN1612894A Methods and compositions of monoclonal antibodies specific for beta-amyloid proteins |
| 05/04/2005 | CN1612750A TACI-immunoglobulin fusion proteins |
| 05/04/2005 | CN1612689A Stable liquid pharmaceutical formulation of IgG antibodies |